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Introduction
Asexual stages of the malaria parasite Plasmodium falciparum 
invade and replicate in human RBCs. During the 48 h of its 
asexual life cycle, the parasite dramatically remodels the host 
RBC (for reviews see Cooke et al., 2001, 2004). This includes 
the generation of unique, fl  attened membranous structures in 
the cytoplasm of the infected RBC (IRBC) called Maurer’s 
clefts and protrusions on the IRBC surface termed knobs. 
P. falciparum also exports several proteins into the host RBC by 
a mechanism that depends on the presence of an NH2-terminal 
motif, termed either the Plasmodium export element (PEXEL) 
or vacuolar transport signal (VTS), which is conserved across 
the Plasmodium genus (Hiller et al., 2004; Marti et al., 2004). 
One of the most important of these exported proteins is PfEMP1 
(P. falciparum erythrocyte membrane protein 1), a protein of para-
site origin that is exposed on the surface of IRBCs and mediates 
adhesion to several receptors expressed on the surface of vascular 
endothelial cells (Baruch et al., 2002). Ultimately, this results in 
the adhesion of mature parasite-infected RBCs to the vascular 
endothelium, which is a process that underpins the development 
of severe and often fatal complications that accompany P. falci-
parum malaria infection in humans (MacPherson et al., 1985; 
Pongponratn et al., 1991). Therefore, understanding the pathways 
and molecular mechanisms by which parasites export proteins to 
the RBC membrane is critical for a complete understanding of the 
pathogenesis of P. falciparum malaria and, in the longer term, 
could lead to the development of novel therapeutic approaches to 
prevent cytoadherence and severe pathological sequelae.
For most parasite proteins that are destined for the RBC 
membrane skeleton and the surface, traffi  cking seems to involve 
Maurer’s clefts (Przyborski et al., 2003; Marti et al., 2004; 
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T
he high mortality of Plasmodium falciparum 
malaria is the result of a parasite ligand, PfEMP1 
(P. falciparum) erythrocyte membrane protein 1), on 
the surface of infected red blood cells (IRBCs), which ad-
heres to the vascular endothelium and causes the seques-
tration of IRBCs in the microvasculature. PfEMP1 transport 
to the IRBC surface involves Maurer’s clefts, which are 
parasite-derived membranous structures in the IRBC 
  cytoplasm. Targeted gene disruption of a Maurer’s cleft 
protein, SBP1 (skeleton-binding protein 1), prevented 
IRBC adhesion because of the loss of PfEMP1 expression 
on the IRBC surface. PfEMP1 was still present in Maurer’s 
clefts, and the transport and localization of several other 
Maurer’s cleft proteins were unchanged. Maurer’s clefts 
were altered in appearance and were no longer found as 
close to the periphery of the IRBC. Complementation of 
mutant parasites with sbp1 led to the reappearance of 
PfEMP1 on the IRBC surface and the restoration of adhe-
sion. Our results demonstrate that SBP1 is essential for 
the translocation of PfEMP1 onto the surface of IRBCs and 
is likely to play a pivotal role in the pathogenesis of 
P. falciparum malaria.
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Knuepfer et al., 2005). Clefts appear at the early trophozoite stage 
of parasite development and persist throughout the   remainder of 
the intra-erythrocytic cycle. The fi  nal destination of Maurer’s 
clefts in IRBCs does appear to be in juxtaposition with the RBC 
membrane skeleton, and there is some evidence to suggest that 
they may interact with actin, ankyrin, or other proteins associated 
with the RBC membrane skeleton such as LANCL1 (Blisnick 
et al., 2000, 2005). It is possible that Maurer’s clefts dock with the
RBC membrane skeleton and provide the exit site for proteins, 
such as PfEMP1, that are exposed on the surface of the IRBC; 
however, such a mechanism has not yet been demonstrated.
Several proteins have been described that are resident 
within Maurer’s clefts, but there is no information about their 
functional roles and whether they may be involved in protein 
traffi  cking (Hawthorne et al., 2004; Vincensini et al., 2005). 
One of the fi  rst Maurer’s cleft proteins to be described was 
P. falciparum SBP1 (skeleton-binding protein 1), a 48-kD integral 
membrane protein that spans the Maurer’s cleft membrane 
(Blisnick et al., 2000). The NH2-terminal domain is found 
within the cleft, whereas the COOH-terminal domain is exposed 
within the IRBC cytoplasm and interacts with a RBC membrane 
skeleton protein, possibly participating in anchoring the clefts 
to the RBC membrane skeleton (Blisnick et al., 2000). To deter-
mine the function of SBP1 in IRBCs, we have generated clonal 
transgenic parasite lines in which SBP1 is not expressed and 
have extensively examined the biological properties of these 
mutant IRBCs. Analysis of the SBP1-deleted parasite line re-
vealed that the major virulence factor PfEMP1 is not expressed 
on the surface of the IRBC and that the wild-type phenotype can 
be restored when the gene deletion is complemented. Impor-
tantly, the SBP1-deleted parasite line (SBP1 knockout [KO]) 
represents the fi  rst P. falciparum parasite line showing a knock-
down in PfEMP1 surface expression.
Results
Disruption of the SBP1 locus
sbp1 (PlasmoDB accession no. PFE0065w) is a 1.2-kb gene 
comprising two exons separated by a 170-bp intron and is lo-
cated in the subtelomeric region of P. falciparum chromosome 5 
(Fig. 1).  To determine the function of SBP1, we disrupted the 
sbp1 gene in P. falciparum 3D7 parasites (Fig. 2 A).  Integration 
of the drug resistance cassette into sbp1 by homologous recom-
bination would disrupt the coding region at residue 192. Eight 
clonal lines were selected from two independent transfection 
events. Of the eight selected clones, three were selected for fur-
ther analysis (1G8, 2D8, and 1G5). Analysis of intact chromo-
somes derived from these transgenic clonal lines, which were 
separated by pulsed fi  eld gel electrophoresis as previously de-
scribed (Kemp et al., 1985), confi  rmed that integration into 
chromosome 5 had occurred (not depicted). Analysis by South-
ern blotting using genomic DNA digested with ClaI and EcoRI 
and probed with either hdhfr (human dihydrofolate reductase) 
or sbp1-F2 confi  rmed that the sbp1 gene had been disrupted in 
all three parasite clones (Fig. 2 B). No episomal plasmid could 
be detected in any of the clones by PCR analysis. Restriction 
fragments of the predicted sizes were also obtained on similar 
Southern blots using DNA digested with alternative endonucle-
ases EcoRI–XhoI or NsiI (not depicted). As expected, the anal-
ysis of three selected parasite clones by Western blotting using 
polyclonal antibodies raised against either NH2- or COOH-
terminal regions of SBP1 (Blisnick et al., 2000) revealed that 
SBP1 expression had been ablated in all three transgenic clones 
(1G5, 1G8, and 2D8; Fig. 2 C). There was no reactivity of any 
of the bands with antibodies against the NH2-terminal region 
of SBP1 with any of the transgenic clones, which is indicative 
of the loss of translation of full-length SBP1. One of the three 
clones (1G8) was selected for more detailed analysis. The ex-
amination of IRBCs infected with 1G8 parasites by immuno-
fl   uorescence using mouse polyclonal antisera specifi  c  for 
SBP1 failed to show any reactivity, suggesting that there were 
no truncated SBP1 products and that SBP1 expression had 
been completely ablated (Fig. 2 D).
Immunoﬂ  uorescence analysis reveals no 
difference in the localization of exported 
parasite proteins to Maurer’s clefts 
in the SBP1 KO line compared with 3D7 
wild-type parasites
Because SBP1 is known to be a major structural component of 
Maurer’s clefts, we wanted to assess Maurer’s cleft structure 
and function in the SBP1 KO line compared with the 3D7 
Figure 1.  Schematic representation of P. falciparum chromosome 5 and the sbp1 locus. (A) Arrangement of genes on P. falciparum chromosome 5 in the re-
gion between 1 and 86 kbp. (B) Expanded view of P. falciparum chromosome 5 between 63 and 81 kbp, indicating the position of sbp1 and ﬂ  anking 
genes. Arrows indicate the direction of transcription. Intragenic distances between sbp1 and neighboring genes are indicated.SBP1 AND TRANSPORT OF PFEMP1 IN MALARIA • COOKE ET AL. 901
wild-type parasites. We fi  rst analyzed the localization of several 
intrinsic Maurer’s cleft markers (Wickham et al., 2001;   
Wickert et al., 2003; Hawthorne et al., 2004) in the two parasite 
lines. As shown in Fig. 3 A, the deletion of SBP1 from 3D7 par-
asites had no apparent affect on the expression or internal cellu-
lar localization of two resident Maurer’s cleft proteins, Pf332 
and REX (ring-stage exported protein).  In addition, we ana-
lyzed proteins that are transiently associated with Maurer’s 
clefts. Both PfEMP1 and KAHRP (knob-associated histidine-
rich protein [HRP]), the major structural component of knobs, 
are still present in the Maurer’s clefts of the SBP1 KO line, and, 
within the limits of discrimination of immunofl  uorescence, 
there appears to be no gross change in the amount of either pro-
tein within Maurer’s clefts (Fig. 3 B). Similarly, PfEMP3, a pro-
tein transported to the IRBC membrane skeleton, is still able to 
reach its customary location (not depicted). Treating IRBCs 
with the pore-forming agent streptolysin O, which increases an-
tibody accessibility to Maurer’s clefts, revealed similar levels 
of PfEMP1 colocalization with another resident Maurer’s cleft 
marker, MAHRP (Maurer’s cleft–associated HRP; Spycher 
et al., 2003) in both parental and SBP1 KO lines (Fig. 3 C).
SBP1 KO parasites show slightly altered 
Maurer’s cleft location and ultrastructure, 
but knob formation and architecture 
are not affected
Examination of transmission electron micrographs of RBCs 
  infected with either 3D7 or 1G8 parasites (Fig. 4) revealed the 
presence of identifi  able Maurer’s clefts in both types of IRBCs.   
Precise quantitation revealed no signifi  cant difference in the 
number of Maurer’s clefts in 1G8 parasites when compared with 
3D7 (1.28 ± 0.16 vs. 1.30 ± 0.16 clefts/μm
2; mean ± SEM for 
Figure 2. Disruption  of  the  sbp1 gene completely abolishes SBP1 expression in IRBCs. (A) Schematic representation of the pHTK∆sbp1 transfection plasmid 
and disruption of the sbp1 gene (3D7Pfsbp1) in P. falciparum 3D7 parasites. The position of relevant restriction enzyme sites ClaI (C) and EcoRI (E) and 
the expected sizes of restriction fragments are indicated. The sbp1 gene locus disrupted by the hdhfr resistance cassette in drug-resistant transfected para-
sites is also shown (3D7∆Pfsbp1). (B) Southern blot analysis of ClaI–EcoRI-digested pHTK∆sbp1 DNA and genomic DNA from 3D7 and three sbp1-deleted 
transgenic clones: 1G5, 1G8, and 2D8. Hybridization of the hdhfr and sbp1-F2 probes to digested DNA from all 3D7∆sbp1 parasite clones revealed 
  restriction fragments consistent with the disruption of sbp1. (C) Western blot analysis of SBP1 expression in 3D7 parasites, sbp1-deleted transgenic clones 
(1G5, 1G8, and 2D8), and the complemented parasite line 1G8/sbp1. Blots were probed with an NH2-terminal anti-SBP1 antibody (top). SBP1 is visual-
ized as a band at  48 kD in the parental 3D7 clonal line. In 1G8/sbp1 parasites, SBP1 is visualized as a slower migrating protein at  75 kD, correspond-
ing to expression of the SBP1-EYFP chimera. Because of the lower level of SBP1-EYFP expression in complemented parasites, a longer exposure (3 min) 
is also shown. Blots were also probed for HSP70 as a loading control (bottom). (D) Immunoﬂ  uorescence analysis of SBP1 in IRBCs infected with either 
3D7 or 1G8 parasites. Note that no ﬂ  uorescence associated with Maurer’s clefts can be seen in the sbp1-deleted 1G8 parasite clone.JCB • VOLUME 172 • NUMBER 6 • 2006 902
1G8 and 3D7 parasites, respectively). In both parasite lines, 
IRBCs with more than one parasite tended to have proportion-
ately more clefts. In a total of 64 random IRBCs examined, only 
one 3D7 IRBC and one 1G8 IRBC had no detectable clefts at all. 
When examined at higher magnifi  cation, however, there were 
subtle detectable differences in the fi  ne morphological structure 
of the clefts, which were typically narrower in RBCs infected 
with 1G8 parasites when compared with RBCs infected with 
3D7 (Fig. 4, G–N). We also examined Maurer’s cleft location in 
the parental 3D7 and KO 1G8 lines, measuring the minimum 
distances of the cleft from the nearest IRBC surface. In both sets 
of samples (number of clefts examined = 37 for each), most 
Figure 3.  Analysis of expression and localization of Maurer’s cleft–associated proteins in IRBCs. (A) Confocal immunoﬂ  uorescence analysis of resident 
(A; REX, SBP1, and Pf332) or transiently associated (B; KAHRP and PfEMP1) Maurer’s cleft proteins in normal (3D7) SBP1-deleted (1G8) and SBP1-
complemented (1G8/sbp1) IRBCs. (C) Colocalization of the resident Maurer’s cleft marker MAHRP with PfEMP1 in streptolysin O–pretreated IRBCs 
demonstrates that PfEMP1 is associated with Maurer’s clefts in both 3D7 and SBP1-deteted parasites.SBP1 AND TRANSPORT OF PFEMP1 IN MALARIA • COOKE ET AL. 903
clefts were approximately parallel to the surface, and, in both, 
about one fi  fth of clefts were angled so as to approach the sur-
face closely. The minimum distance from the cell surface to the 
Maurer’s cleft in 3D7 IRBCs was 139 ± 12 nm (mean ± SEM), 
whereas in the SBP1 KO line, Maurer’s clefts were on average 
slightly further from the IRBC surface (160 ± 15 nm).
By scanning electron microscopy, the external appear-
ances of 3D7 or 1G8 IRBCs were similar, with irregular sur-
faces bearing numerous knobs (Fig. 4, E and F). The knobs on 
both 3D7 and 1G8 IRBCs also looked identical by transmis-
sion electron microscopy (Fig. 4, A–D; black arrows). Precise 
quantitation revealed that there were no signifi  cant differences 
between the number of knobs on 1G8 IRBCs when compared 
with 3D7 IRBCs (3.43 ± 0.31 vs. 3.45 ± 0.31 knobs/μm
2; 
mean ± SEM for 1G8 and 3D7, respectively). In both para-
site lines, IRBCs with more than one parasite tended to have 
proportionately more knobs. In the total of 64 random IRBCs 
examined, only one 3D7 IRBC and one 1G8 IRBC had no 
  detectable knobs at all.
Transport of PfEMP1 is arrested 
at Maurer’s clefts in SBP1-deleted 
parasite lines
To examine the fate of PfEMP1 in detail, we performed various 
immunochemical and proteolytic assays on surface-exposed 
PfEMP1 in both parental and mutant parasite lines. It has previ-
ously been shown that PfEMP1 changes its solubility during 
transport to the IRBC surface. Specifi  cally, the protein is solu-
ble in Triton X-100 during transport in the IRBC but becomes 
detergent insoluble/SDS soluble when incorporated into the 
knob structure on the IRBC surface (Kriek et al., 2003). In addi-
tion, the large NH2-terminal PfEMP1 exodomain is sensitive to 
trypsin when the protein is surface exposed (Waterkeyn et al., 
2000). We analyzed the distribution of PfEMP1 in both wild-
type and SBP1 KO parasites by Western blot analysis of the 
  Triton X-100–insoluble/SDS-soluble fraction of membrane 
proteins with and without trypsin treatment of intact IRBCs 
(Fig. 5).  Thus, in the parental 3D7 line, PfEMP1 was present in 
the Triton X-100–insoluble/SDS-soluble fraction and was 
cleaved after exposure to trypsin. In contrast, PfEMP1 was not 
present in the Triton X-100–insoluble/SDS-soluble fraction in 
the SBP1 KO line, and the protein was not sensitive to trypsin 
treatment (Fig. 5 A). To control for trypsin digestion, we exam-
ined the fate of an integral membrane and surface-exposed pro-
tein of human RBCs, glycophorin C, in both parental and mutant 
parasite lines. In both cases, glycophorin C was cleaved by the 
exogenous trypsin, demonstrating that PfEMP1 in the SBP1 KO 
line was not present on the IRBC surface but remained internal 
within the Maurer’s clefts as shown by immunofl  uorescence 
  assay (IFA; Fig. 3 C). The relative differences in the amount of 
PfEMP1 in this Triton X-100–insoluble fraction can be more 
readily visualized after the extensive preabsorption of anti-
PfEMP1 antiserum against inside-out RBCs to reduce cross-
  reactivity of the antiserum with RBC spectrin (Fig. 5 B). There is
almost no detectable product in the KO parasite line, suggesting 
that there is no intermediate compartment between residence in 
the Maurer’s cleft and exposure on the surface. It also suggests 
that PfEMP1 has not exited the cleft but becomes trapped in as-
sociation with the membrane skeleton en route to the IRBC sur-
face. Together with our IFA experiments (Fig. 3), these data are 
consistent with a block in the surface expression of PfEMP1 at 
the level of the Maurer’s clefts in the SBP1 KO parasite line.
Figure 4.  Ultrastructural analysis of IRBCs. 
Comparisons of Maurer’s clefts and surface 
knob appearances in RBCs infected with wild-
type 3D7 (A, B, E, and G–J) or sbp1-  deleted 
1G8 parasites (C, D, F, and K–N). Survey 
transmission electron micrographs of 3D7 
(A and B) and 1G8 (C and D) show that both 
express Maurer’s clefts (white arrows) and 
knobs (black arrows), and scanning electron mi-
croscopy of 3D7 (E) and 1G8 (F) also shows a 
similar expression of knobs. However, transmis-
sion electron microscopy at higher magniﬁ  ca-
tions shows differences between 3D7 clefts 
(G–J) and those of 1G8 (K–N), in which clefts 
are typically narrower with a reduced intermem-
brane space; shown in higher magniﬁ  cation 
in J (3D7) and N (1G8). pv, pigment vacuole.JCB • VOLUME 172 • NUMBER 6 • 2006 904
RBCs infected with SBP1-deleted 
parasites do not adhere to CD36 
under static or ﬂ  ow conditions
Cytoadherence of IRBCs is mediated by the differential binding 
properties of variant PfEMP1 exodomains to several host cell 
receptors. The absence of PfEMP1 expression on the surface of 
IRBCs should, therefore, result in reduced cytoadherence in 
the 1G8 parasite line compared with wild-type 3D7 parasites. 
Because 3D7 parasites bind only to the endothelial cell surface–
expressed receptor CD36, we quantifi  ed the adhesion of IRBCs 
to this receptor using both static and fl  ow-based adhesion 
assays. In static assays, the ability of RBCs infected with 1G8
parasites to adhere was signifi  cantly reduced by >96% when 
compared with the level of adhesion for 3D7 IRBCs (mean 
  reduction in adhesion = 96.7 ± 1.3%; mean ± SEM for fi  ve 
experiments; P < 0.01 by Mann-Whitney U test). Similarly, 
when tested under fl  ow conditions (at 0.1 Pa), all three trans-
genic sbp1-deleted parasite clones showed signifi  cantly reduced 
adhesion to CD36 (Fig. 6).  The low level of binding was similar 
for all three transgenic clones, averaging only 12% of the level 
for 3D7 (P < 0.01 by Kruskall Wallace test).
Expression of an sbp1-EYFP chimeric gene 
in 1G8 parasites restores surface PfEMP1 
expression and adhesion of IRBCs to CD36
We reintroduced a full-length sbp1 gene from 3D7 parasites 
under control of the constitutive P. falciparum hsp86 (heat 
shock protein 86) promotor into 1G8 parasites by transfection of 
the modifi  ed Gateway expression vector pHrB1-1/2 containing 
the 3D7 sbp1 gene that had been amplifi  ed from cDNA and 
  appended to the reporter protein EYFP. Examination of drug-
  resistant parasites by Western analysis  80 d after transfection 
revealed that the resulting parasites, 1G8/sbp1, were clearly 
  producing SBP1, although at a somewhat lower level than seen 
in wild-type parasites (Fig. 2 C). When live IRBCs were viewed 
under 513-nm blue light, Maurer’s clefts were visualized as 
 fl uorescing structures throughout the cytoplasm of the IRBC, with 
a proportion of clefts in close association with the RBC mem-
brane skeleton (Fig. 7).  Analysis of these 1G8/sbp1 parasites 
by immunofl  uorescence and confocal microscopy revealed that the 
SBP1-EYFP chimeric protein was traffi  cked correctly to Maurer’s 
clefts that were located at the RBC membrane skeleton (Figs. 3 
and 7). The SBP1-EYFP protein also colocalized with REX 
(Fig. 3) and other Maurer’s cleft markers (Pf332 and KAHRP; 
not depicted), demonstrating that the SBP1-EYFP chimeric 
  protein was being traffi  cked to its native cellular location.
The effect of complemented SBP1 on PfEMP1 was exam-
ined in two independent cloned lines derived from 1G8, 1G8/
sbp1, and 1G8/sbp1.1. Reintroduction of SBP1 led to the reappear-
ance of PfEMP1 on the surface of the IRBC and the restoration 
of cytoadherence to CD36. Surface expression could be demon-
strated by the reappearance of PfEMP1 in the Triton X-100–
  insoluble/SDS-soluble fraction, demonstrating an association 
Figure 5.  Analysis of surface-exposed PfEMP1 on IRBCs by trypsin cleavage 
assay.  (A) Western blot analysis of Triton X-100–insoluble/SDS-soluble 
membrane fractions from intact, uninfected RBCs or IRBCs (3D7, 1G8, 
1G8/sbp1, and 1G8/sbp1.1) either before (−) or after (+) treatment with 
trypsin. The two bands below full-length PfEMP1 at  250 kD represent 
cross-reactivity with the RBC cytoskeletal proteins α and β spectrin. An 
identical blot was probed with mouse antiglycophorin C antibody (GpC) 
as a control for trypsin activity. An 80-kD band was detected in 3D7 para-
sites (VARC) representing the cytoplasmic domain of surface-exposed 
PfEMP1 in these IRBCs. Note the absence of this band in the sbp1-deleted 
parasite clone (1G8), conﬁ   rming a lack of surface-exposed PfEMP1 in 
these IRBCs. The complemented 1G8/sbp1 parasite clone shows the re-
appearance of a trypsin-cleavable PfEMP1, although its cytoplasmic domain 
appears to be larger ( 115 kD) than that detected in 3D7 parasites, 
suggesting surface exposure of a different CD36-binding PfEMP1 variant. 
Analysis of a second complemented clonal line (1G8/sbp1.1), which 
  expresses the original 1G8 var, shows that PfEMP1 is surface exposed 
as indicated by the restoration of trypsin cleavage. (B) A similar blot to 
that shown in A but probed with anti-PfEMP1 antibody after preabsorption 
with inside-out RBCs to reduce spectrin cross-reactivity. The absence of 
full-length PfEMP1 on the surface of SBP1 KO IRBCs is notable. An iden-
tical blot was probed for HSP70 as a parasite loading control.
Figure 6.  Adhesive properties of IRBCs under ﬂ  ow conditions. The level of 
adhesion of IRBCs to CD36 under ﬂ  ow conditions (0.1 Pa). Adhesion rep-
resents the number of IRBCs that adhered for three SBP1-deleted parasite 
clones (1G8, 2D8, and 1G5) as a percentage of parental 3D7 IRBCs. 
Note the restoration of the adhesive phenotype of the complemented 
1G8/sbp1 IRBCs back to the level of adhesion measured for the parental 
3D7 line. Data represent the mean ± SEM (error bars) for ﬁ  ve independent 
experiments for each parasite clone.SBP1 AND TRANSPORT OF PFEMP1 IN MALARIA • COOKE ET AL. 905
with the membrane skeleton (Fig. 5 A). Importantly, PfEMP1 
was once again sensitive to trypsin digestion, confi  rming an 
  exposed location on the IRBC surface. Of interest is that the 
two complemented lines derived from 1G8 differ in the variant 
of  PfEMP1 they express on the IRBC surface. 1G8/sbp1.1 
  expresses a variant of PfEMP1 that is unchanged in size from 
3D7, whereas 1G8/sbp1 has undergone a var gene switch to 
  express a different variant of PfEMP1. Importantly, this demon-
strates that SBP1 has a general role in PfEMP1 traffi  cking and 
is not specifi  c to a particular PfEMP1 variant.
Reintroduction of the full-length sbp1 gene into 1G8 par-
asites also dramatically restored the ability of both comple-
mented lines to adhere to CD36 under both static and fl  ow 
conditions. For example, in static assays, the reintroduction of 
sbp1 into 1G8 parasites restored adhesion such that 1G8/sbp1 
IRBCs bound at levels  60-fold higher than 1G8 IRBCs 
(76.1 ± 16.5% vs. 1.3 ± 1.3%; mean ± SEM for 1G8/sbp1 and 
1G8 parasite clones, respectively). Similarly, when tested under 
fl  ow, adhesion of 1G8/sbp1 IRBCs showed a level of binding 
similar to that measured for 3D7 IRBCs (Fig. 6). Interestingly, 
the 1G8/sbp1.1 complemented line showed a consistently 
higher level of adhesion in both static and fl  ow assays when 
compared with the wild-type 3D7 (not depicted). The amount 
of surface-exposed PfEMP1 that exerts this adhesive effect 
would appear to be quite small, as there is no detectable differ-
ence in appearance by IFA of either 1G8 or the complemented 
parasite lines (Fig. 3).
Discussion
Traffi  cking of PfE MP1 in P. falciparum–IRBCs has been exam-
ined by several groups recently and has been shown convinc-
ingly to occur in association with Maurer’s clefts (Wickham 
et al., 2001; Kriek et al., 2003; Wickert et al., 2003; Marti et al., 
2004; Knuepfer et al., 2005; Papakrivos et al., 2005). Exit from 
the parasite into the RBC cytoplasm is under the direction of a 
protein export motif known as the PEXEL or VTS (Hiller et al., 
2004; Marti et al., 2004), and initial transport within the IRBC 
cytoplasm appears to be as soluble protein complexes rather 
than via vesicles (Kriek et al., 2003; Knuepfer et al., 2005; 
  Papakrivos et al., 2005). PfEMP1 then appears to be inserted 
into the Maurer’s cleft membrane, although is not clear whether 
the protein is transported within the cleft itself or attached to 
the cytoplasmic face of the cleft, as the resolution of light 
  microscopic studies is insuffi  cient to answer this question. Once 
Maurer’s clefts reach the RBC membrane skeleton, PfEMP1 
becomes anchored at the knob structures, and its extra-
cellular binding domains become exposed on the RBC surface. 
Although it is clear that the export of PfEMP1 from the para-
site to the IRBC cytoplasm is dependent on a functional 
PEXEL/VTS motif, it is still unknown precisely how PfEMP1 
accomplishes the fi  nal translocation across the RBC membrane 
and what, if any, parasite or host molecules are involved in 
this process. It is likely that such molecules would either be 
present at the RBC surface, probably within the knob structure, 
or would be found in association with Maurer’s clefts.
SBP1 has previously been shown to be a membrane pro-
tein resident in Maurer’s clefts that is oriented so that its COOH-
terminal domain is present in the RBC cytoplasm (Blisnick 
et al., 2000). Its function was previously unknown, although it 
has been suggested that it might be involved in binding the cleft 
to the RBC membrane skeleton through a specific interaction 
with proteins of the RBC membrane skeleton such as actin 
(Blisnick et al., 2000) or RBC membrane–associated proteins 
such as LANCL1 (Blisnick et al., 2005). SBP1 is clearly not an 
essential structural protein of the cleft, as its absence does not 
affect cleft morphology or number markedly. The subtle changes 
in cleft morphology related to the deletion of SBP1 noted in our 
studies here may merely represent the loss of SBP1 itself or the 
loss of a group of associated proteins that are anchored to the 
cleft by interaction with SBP1. We also conclude that it is not a 
required part of the general traffi  cking mechanism for parasite 
proteins exported to the RBC as Maurer’s cleft–associated pro-
teins because PfEMP3, Pf332, KAHRP, REX, and MAHRP are 
traffi  cked normally to the membrane skeleton of RBCs infected 
with sbp1-deleted parasites. Furthermore, the cytoadherence-
related knob complexes on the surface of the IRBC form nor-
mally in sbp1-deleted parasite clones.
In fact, SBP1 appears to have a precise function, which is 
to mediate the fi  nal step in the translocation of PfEMP1 on to 
the surface of the IRBC. We conclude this from our  observations 
that PfEMP1 is present in Maurer’s clefts in an sbp1-deleted 
parasite line but does not appear on the surface of RBCs in-
fected with mature stage parasites. The failure of PfEMP1 to 
reach the RBC surface leads to a loss of binding of IRBCs to 
Figure 7.  Restoration of SBP1 expression by gene complementation. 
(A) Immunoﬂ   uorescence analysis of 1G8 and 1G8/sbp1 IRBCs using 
a mouse polyclonal SBP1 (for 1G8 IRBCs) or rabbit anti-GFP polyclonal 
(for 1G8/sbp1 IRBCs). Note the absence of SBP1 in the sbp1-deleted para-
site clone 1G8 and the reappearance of SBP1 associated with Maurer’s 
clefts that are associated with the RBC skeleton in RBCs infected with the 
complemented 1G8/sbp1 parasite clone. (B) A live trophozoite-infected 
RBC showing green-ﬂ  uorescing Maurer’s clefts in the cytoplasm of a RBC 
parasitized by 1G8/sbp1 parasites when viewed under 513-nm blue/
green light as a result of the presence of the EYFP reporter protein 
appended to the COOH terminus of the chimeric sbp1 gene.JCB • VOLUME 172 • NUMBER 6 • 2006 906
CD36 both in static and fl  ow-based adhesion assays. Reintro-
duction of the SBP1 protein leads to the reappearance of PfEMP1 
on the IRBC surface and restoration of the capacity of IRBCs to 
adhere to CD36. What is the mechanism by which SBP1 has 
this effect on PfEMP1 traffi  cking? Our evidence would suggest 
that this is not caused by a direct physical interaction between 
PfEMP1 and SBP1. First, analysis of the SBP1 protein sequence 
does not reveal any domains with homology to known protein 
chaperones or to proteins known to be involved in protein 
 traffi  cking or vesicular transport of proteins. Second, immuno-
precipitation of SBP1 from IRBC lysates does not lead to the 
coprecipitation of PfEMP1 (Fig. S1, available at http://www.
jcb.org/cgi/content/full/jcb.200509122/DC1). Third, acceptor 
photobleaching fl  uorescent resonance energy transfer (FRET) 
experiments in which PfEMP1 and SBP1 were labeled with 
FRET-compatible fl  uorophores did not lead to the detectable 
transfer of energy from one molecule to the other (Fig. S1). This 
suggests that they are not found in close contact as would be 
  expected in directly interacting proteins. Finally, a recent study 
devoted to the P. falciparum interactome reported the interac-
tions of PfEMP1 and SBP1 with other proteins in the parasite 
but did not fi  nd a direct interaction between the two (LaCount 
et al., 2005). Collectively, these data suggest that the effect of 
SBP1 on PfEMP1 transport is indirect. At present, the data are 
most compatible with the hypothesis that the alterations in 
Maurer’s cleft morphology and distance to the IRBC surface 
leads to changes that make the fi   nal translocation step of 
PfEMP1 markedly ineffi  cient. These changes are subtle, and 
this is likely to be the reason why traffi  cking of only one  protein, 
PfEMP1, is interfered with and not others such as KAHRP, 
which presumably have more margin for error in the relatively 
straightforward process of binding to nearby spectrin. In con-
trast, PfEMP1 must successfully perform translocation across 
another membrane to reach its fi  nal destination, presumably 
using the transmembrane and COOH-terminal domains of 
PfEMP1, as these have been demonstrated to be suffi  cient for 
translocation of the protein across the RBC membrane (Knuepfer 
et al., 2005). Whatever the ultimate mechanism, it is clear that 
SBP1 has a general role in PfEMP1 traffi  cking as surface local-
ization of PfEMP1 is restored in complemented lines  expressing 
variant forms of the protein.
The specifi  c function of SBP1 in PfEMP1 translocation 
is consistent with its phylogenetic distribution within malaria 
species. We have examined several Plasmodium spp. genomes 
and are unable to identify a homologue of sbp1 either by direct 
homology searching using the Basic Local Alignment Search 
Tool (BLAST) or Position-Specifi  c Iterated BLAST. The sbp1 
gene is located between the genes for the exported parasite pro-
teins mesa and fi r a  at the subtelomeric end of chromosome 5 in 
P. falciparum. Orthology searches in the Plasmodium genome 
database (www.PlasmoDB.org) revealed that synteny between 
P. falciparum chromosome 5 and a contig from both Plasmodium 
vivax and Plasmodium yoelii breaks down at the rap2 locus. 
This suggests that the more subtelomeric part of chromosome 5, 
including fi r a , sbp1, and mesa, is specifi  c only to P. falciparum 
(Fig. 1). Other species of Plasmodium lack a PfEMP1-like mol-
ecule, so it is reasonable that a protein specifi  c for translocation 
should also be absent from the same species. In this context, it 
is interesting to note that deletion of the subtelomeric end of 
chromosome 2 of P. falciparum (which frequently occurs within 
the kahrp locus) results in the loss of knobs and cytoadherence 
of IRBCs, although PfEMP1 is still expressed on the IRBC sur-
face (Cooke et al., 2002c). In addition, the kahrp locus is also 
the breakpoint of synteny between P. falciparum chromosome 2 
and a large P. vivax contig (Sargeant et al., 2006). This supports 
the idea of a few P. falciparum–specifi  c subtelomeric loci that 
are critical for the transport and function of PfEMP1 and, con-
sequently, in cytoadherence of IRBC to host vascular endothe-
lium. The absence of sbp1 in other malaria species that express 
proteins on the surface of the IRBC and that are involved in an-
tigenic variation such as the yir, vir, and kir gene families (col-
lectively termed the Plasmodium interspersed repeat superfamily 
[pir]; Janssen et al., 2004) also suggests that these molecules 
reach the surface of the IRBC by some other mechanism. As 
RIFINs are the P. falciparum representatives of the pir family 
in that species, it seems very likely that their traffi  cking to the 
IRBC surface in P. falciparum occurs by an SBP1-independent 
mechanism. We cannot examine this directly in our sbp1 KO 
line because it is generated on a 3D7 parasite background, a line 
that does not express detectable RIFINs on the RBC surface 
(Kyes et al., 1999).
In conclusion, we show here, for the fi  rst time, that the 
Maurer’s cleft–associated protein SBP1 plays a major role in 
translocation of the cytoadherence ligand PfEMP1 onto the sur-
face of P. falciparum–infected RBCs. We have demonstrated 
this via complementation of a gene KO parasite line, which is 
the fi  rst study to our knowledge of the complementation of a 
blood stage gene in Plasmodium spp. Future studies will be 
aimed at identifying the precise mechanisms and interactions 
involved in this process and whether other molecular players 
are involved. Such knowledge might be used to interfere with 
the translocation process, which in vivo would be likely to be 
associated with a marked decrease in parasite virulence and 
may constitute a new therapeutic approach to the control of ma-
laria infection in humans in the future. The availability of spe-
cifi   c PfEMP1-null lines also makes possible new studies 
examining such questions as the importance of PfEMP1 in the 
pathogenesis of malaria by, for example, the disruption of SBP1 
in monkey-adapted parasite lines and subsequent infection of 
primate hosts. If such parasite lines are avirulent in the verte-
brate host, they could become the basis of a genetically defi  ned 
attenuated vaccine for use in humans.
Materials and methods
Malaria parasites
P. falciparum parasites (3D7) were maintained in continuous in vitro culture 
in human RBCs suspended in Hepes-buffered RPMI 1640 supplemented 
with 0.5% AlbumaxII using standard procedures (Cranmer et al., 1997). 
Cultures were kept synchronous, and the knob-positive phenotype was 
maintained by gelatin ﬂ  oatation (Waterkeyn et al., 2001). Clonal parasite 
lines were derived by the method of limiting dilution.
Plasmid constructs
To disrupt the sbp1 gene in 3D7 parasites, 5′ and 3′ sequences of  1 kb 
ﬂ  anking  the  sbp1 gene were cloned into the P. falciparum transfection 
plasmid pHHT-TK (gift from A. Cowman and B. Crabb, The Walter and SBP1 AND TRANSPORT OF PFEMP1 IN MALARIA • COOKE ET AL. 907
Eliza Hall Institute, Melbourne, Australia; Duraisingh et al., 2002) to 
derive pHTK∆sbp1 (Fig. 2 A). Speciﬁ  cally, the 5′ segment of sbp1 (including 
458 bp of the 5′ untranslated sequence) was ampliﬁ  ed from genomic DNA 
from 3D7 parasites using forward and reverse primers 5′TCCCCGCGGc-
gatacaaccctccttttatg3′ (SacII site underlined) and 5′GGACTAGTgacatag-
attcggctgga3′ (SpeI site underlined), respectively, and was subcloned into 
the SacII and SpeI sites of pHHT-TK upstream of the hdhfr resistance 
cassette. The 3′ segment of sbp1 (including 437 bp of the 3′ untranslated 
sequence) was ampliﬁ   ed using the forward and reverse primers 
5′CGGAATTCgcagattttgcaaaacaagc3′ (EcoRI site underlined) and 
5′C  A  T  G  C  C  A  T  G  G  catatacataaacgatcaaaag3′ (NcoI site underlined), re-
spectively, and was introduced into the EcoRI and NcoI sites downstream 
of the hdhfr cassette. Plasmid DNA was ampliﬁ  ed in Escherichia coli and 
puriﬁ  ed using MegaPrep (QIAGEN).
For complementation, the full-length sbp1 gene (excluding the 
stop codon) was PCR ampliﬁ  ed from 3D7 cDNA using the forward and 
  reverse primers 5′C  A  C  C  T  A  T  A  T  A  C  A  atgtgtagcgcagctcgagca3′ and ggtttctc-
tagcaactgtttttg, respectively, and was cloned using topoisomerase into the 
multisite Gateway entry vector pENTR/D-TOPO (Invitrogen). This was re-
combined together with pDONR P4-P1R vector containing the P. falciparum 
Hsp86 promoter and pDONR P2R-P3 vector containing the EYFP reporter 
gene into a destination vector, pHrB1-1/2, that had been previously 
  modiﬁ  ed for use in P. falciparum (van Dooren et al., 2005) to produce the 
expression plasmid pHrB1-1/2-sbp1.
Parasite transfection
Ring-stage parasites were transfected by electroporation with 150 μg of 
puriﬁ   ed supercoiled plasmid DNA (pHTk∆sbp1) diluted in cytomix 
  according to standard procedures (Wu et al., 1996) but using modiﬁ  ed 
electroporation conditions to enhance DNA delivery (Fidock and 
Wellems, 1997). Transfected parasites were cultured in the presence 
of 2.5 nM of the antifolate drug WR99210 (Fidock and Wellems, 1997) 
for   30 d until viable parasites were observed in Giemsa-stained 
smears. 4 μM ganciclovir (Roche Diagnostics) was then added to select 
for parasites having only double crossover homologous recombination 
(Duraisingh et al., 2002). For complementation, positive selection for 
parasites transformed with pHrB1-1/2-sbp1 was performed using 8 μM 
blasticidin S hydrochloride (Calbiochem) as previously described 
  (Mamoun et al., 1999).
DNA extraction and Southern blotting
Genomic DNA was extracted from parasite culture using the Nucleon 
BACC2 kit (GE Healthcare), digested with ClaI and EcoRI, separated on 
1% agarose gels, and transferred to nylon membranes. Southern blot 
  hybridization was performed using standard procedures.
Western blotting
Cultured IRBCs were harvested on Percoll and solubilized in 2× reducing 
SDS sample buffer containing protease inhibitor cocktail (Roche Diagnostics). 
These total parasite extracts were separated on 10% SDS-PAGE gels and 
transferred to polyvinylidene diﬂ   uoride (PVDF) membranes. Membranes 
were probed with rabbit polyclonal anti-HSP70 (1:10,000), mouse poly-
clonal anti-SBP1 (1:400), or mouse monoclonal antiglycophorin C (1:500; 
Sigma-Aldrich) antibodies. Detection by enhanced chemiluminescence 
(Lumi-light Western blotting substrate; Roche Diagnostics) was performed 
after secondary detection with either sheep anti–rabbit or sheep anti–
mouse Ig-HRP conjugate (1:2,000; Silenus).
Analysis of PfEMP1 expression on the surface of IRBCs by trypsin 
cleavage assay
The trypsin cleavage assay was performed as previously described 
  (Waterkeyn et al., 2000) to visualize PfEMP1 expressed on the IRBC surface. 
In brief, mature IRBCs were enriched on Percoll as previously described 
(Dluzewski et al., 1984) and were incubated with 100 μg/ml TPCK-
treated trypsin (Sigma-Aldrich) in the presence or absence of 1 mg/ml 
soybean trypsin inhibitor (STI; Sigma-Aldrich) for 15 min at 37°C. Reac-
tions were stopped by the addition of STI to a ﬁ  nal concentration of 1 mg/ml 
followed by a further incubation of 15 min at room temperature. Membrane 
proteins (including PfEMP1) were extracted using Triton X-100 and SDS 
solubilization as described previously (Van Schravendijk et al., 1993) and 
diluted in reducing Laemmli sample buffer. Samples were separated on 6% 
SDS-PAGE gels and transferred for 4 h at 4°C onto PVDF membranes. 
The cytoplasmic tail of PfEMP1 (VARC) was detected using the mouse 
monoclonal antibody 1B/98-6H1-1 (1:100; gift from The Walter and 
Eliza Hall Institute).
Fluorescence and confocal microscopy
For indirect immunoﬂ  uorescence, cultured RBCs were ﬁ  xed in suspension 
with 4% PFA containing 0.0075% glutaraldehyde in PBS, permeabilized 
with 0.1% Triton X-100, and blocked with 3% BSA in PBS as previously 
described (Tonkin et al., 2004). Cells were then incubated for 1 h with either 
mouse polyclonal anti-SBP1 (1:500), rabbit polyclonal anti-KAHRP (1:500), 
rabbit polyclonal anti-Pf332 (1:200), rabbit polyclonal anti  –REX-1 
(1:2,000; gift from D. Gardiner, Queensland Institute of Medical Research, 
Brisbane, Australia), mouse polyclonal anti–MAHRP-1 (1:200; gift from 
C. Spycher and H.-P. Beck, Swiss Tropical Institute, Basel, Switzerland), or 
rabbit polyclonal anti-GFP (1:1.000; Invitrogen). For PfEMP1 localization 
using rabbit polyclonal anti-VARC (1:100), detection was performed using 
thin culture smears that had been air dried and ﬁ  xed with cold acetone/
methanol (9:1) because this antibody showed poor reactivity when used 
on RBCs that had been ﬁ  xed with PFA/glutaraldehyde in suspension using 
the method of Tonkin et al. (2004). Primary antibodies were then detected 
using either anti–mouse or anti–rabbit IgG conjugated to AlexaFluor488 
or -568 (Invitrogen) and visualized using a laser-scanning confocal 
  microscope (model TCS NT; Leica) equipped with a krypton/argon laser
(488/568 nm). The confocal scan head was mounted on an inverted 
  microscope (model DM RBE; Leica) equipped with a 100× NA 1.4 oil 
plan-Apo objective. All images of individual RBCs shown in ﬁ  gures are 
representative of numerous similar RBCs in multiple ﬁ  elds of view. Green 
ﬂ   uorescence of EYFP-expressing transformants was observed using live 
  unﬁ  xed RBCs directly from culture under 513-nm light using a ﬂ  uorescence 
microscope (BX51; Olympus).
Morphometric analysis of knobs and Maurer’s clefts 
by electron microscopy
RBCs from synchronous cultures containing predominantly mature stage 
parasites (late trophozoites/young schizonts) were ﬁ  xed by the dilution of 
packed RBCs into isotonic PBS containing 2.5% (vol/vol) electron micros-
copy grade glutaraldehyde (Sigma-Aldrich). After routine preparative 
  procedures (Bannister et al., 2003), ultrathin sections were prepared for 
transmission electron microscopy and pelleted for SEM. Random   images of 
IRBCs were captured digitally at a magniﬁ  cation of 20,000× in an   electron 
microscope (H7600; Hitachi) and analyzed using Scion Image software 
(v4.0.2). Electron-dense knobs and Maurer’s clefts were counted manually 
for each IRBC. A total of 32 IRBCs were examined for each of the parasite 
lines 3D7 and 1G8. Parameters measured were (1) the perimeter of each 
IRBC, (2) the total sectional area of each IRBC, and (3) the sectional area 
of the parasite (if more than one parasitewas   present, their areas were 
added together). From the second and third   parameters, the area of IRBC 
external to the parasite was obtained by subtraction. Knobs and Maurer’s 
clefts were counted manually to determine their frequencies.
IRBC adhesion assays
The adhesive properties of IRBCs were quantiﬁ  ed using both static and 
ﬂ  ow-based assays. Parasite cultures were tested when the majority of para-
sites were pigmented trophozoites as assessed by Giemsa-stained smears. 
Cultured RBCs were resuspended in adhesion buffer (Hepes-buffered RPMI 
1640 supplemented with 1% BSA and pH adjusted to 7.0) to a concentra-
tion of  3 × 10
8 RBCs/ml for static adhesion assays or 1.5 × 10
8 RBCs/ml 
for ﬂ  ow-based assays. For all adhesion assays, the parasitemia averaged 
 4.4% trophozoites (range of 2.2–7.8%). Static assays were performed in 
36-mm petri dishes as previously described (Beeson et al., 1998) except 
that puriﬁ  ed recombinant CD36 (R&D Systems) was immobilized as the 
target receptor (100 μg/ml). Adhesion to CD36 under ﬂ  ow conditions that 
mimic those in postcapillary venules was visualized and quantiﬁ  ed in vitro 
by direct microscopic observation on a microscope (IMT-2; Olympus) with 
a 40× water immersion objective (Olympus) using ﬂ  at, rectangular glass 
microcapillary tubes (Microslides; VitroCom, Inc.) connected to a ﬂ  ow-
  control system as previously described (Cooke et al., 2002a,b).
Online supplemental material
Fig. S1 shows the results from immunoprecipitation and FRET experi-
ments to demonstrate that there is no direct molecular interaction between 
SBP1 and PfEMP1 in IRBCs infected with 3D7 parasites. Supplemental 
text provides details of these FRET and immunoprecipitation experiments. 
Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.200509122/DC1.
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